Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Thomas QD"'
Autor:
Bastin T; CHU de Caen, avenue Côte de Nacre, 14033 Caen cedex, France., Thomas QD; Département d'oncologie médicale, institut régional du cancer de Montpellier, 34298 Montpellier cedex, France. Electronic address: Quentin.thomas@icm.unicancer.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2024 Nov; Vol. 111 (11), pp. 1000-1002. Date of Electronic Publication: 2024 Sep 20.
Autor:
Thomas QD; Department of Medical Oncology, Institut du Cancer de Montpellier, 34000 Montpellier, France., Girard N; Department of Medical Oncology, Institut Curie, 75005 Paris, France., Bosquet L; Unicancer, 75000 Paris, France., Cavaillon S; Department of Medical Oncology, Institut du Cancer de Montpellier, 34000 Montpellier, France., Filleron T; Biostatistics Unit, Oncopôle Claudius Régaud IUCT-O, 31100 Toulouse, France., Eltaief S; Unicancer, 75000 Paris, France., Chouaid C; Department of Pneumology, Centre Hospitalier Intercommunal, 94010 Créteil, France., Lena H; Pneumology Department, CHU Pontchaillou, 35000 Rennes, France., Debieuvre D; Respiratory Medicine Department, Groupe Hospitalier de la Région Mulhouse Sud-Alsace, 68100 Mulhouse, France., Perol M; Department of Medical Oncology Centre Léon Bérard, 69008 Lyon, France., Quantin X; Department of Medical Oncology, Institut du Cancer de Montpellier, 34000 Montpellier, France.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Oct 23; Vol. 16 (21). Date of Electronic Publication: 2024 Oct 23.
Autor:
de Borms AT; Department of Medical Oncology, Montpellier Cancer Institute (ICM), 34090, Montpellier, France., Colard-Thomas J; Department of Medical Oncology, Montpellier Cancer Institute (ICM), 34090, Montpellier, France., Laurent PI; Department of Radiotherapy, Montpellier Cancer Institute, 34090, Montpellier, France., Coget E; Pharmacy Department, University Hospital of Nîmes, 30900, Nîmes, France., Carbasse C; Pharmacy Department, University Hospital of Nîmes, 30900, Nîmes, France., Annakib S; University of Montpellier, 34090, Montpellier, France., Thomas QD; Department of Medical Oncology, Montpellier Cancer Institute (ICM), 34090, Montpellier, France.; University of Montpellier, 34090, Montpellier, France., Nicolas E; Medical Oncology Department, University Hospital of Nîmes, 30900, Nîmes, France., Fiteni F; University of Montpellier, 34090, Montpellier, France. frederic.fiteni@chu-nimes.fr.; Medical Oncology Department, University Hospital of Nîmes, 30900, Nîmes, France. frederic.fiteni@chu-nimes.fr.; UMR INSERM IDESP-Desbrest Institute of Epidemiology and Public Health, University of Montpellier, 34090, Montpellier, France. frederic.fiteni@chu-nimes.fr.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jun 22; Vol. 32 (7), pp. 452. Date of Electronic Publication: 2024 Jun 22.
Autor:
Thomas QD; Department of Medical Oncology, Montpellier Cancer Institute, Montpellier; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute, University of Montpellier, Montpellier., Quantin X; Department of Medical Oncology, Montpellier Cancer Institute, Montpellier; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute, University of Montpellier, Montpellier., Lemercier P; Biometrics Unit, Montpellier Cancer Institute, University of Montpellier, Montpellier., Chouaid C; Department of Pneumology, Intercommunal Hospital Créteil, Créteil., Schneider S; Department of Pneumology, Hospital Center Côte Basque, Bayonne., Filleron T; Biostatistics Unit, Claudius Regaud Institute IUCT-O, Toulouse., Remon-Masip J; Thoracic Unit, Gustave Roussy, Villejuif., Perol M; Department of Medical Oncology, Centre Leon Berard, Lyon., Debieuvre D; Department of Pneumology, GHR Mulhouse Sud-Alsace, Mulhouse., Audigier-Valette C; Department of Pneumology, Intercommunal Hospital, Toulon., Justeau G; Department of Pneumology, University Hospital, Angers., Loeb A; Department of Medical Information, Centre Henri Becquerel, Rouen., Hiret S; Department of Medical Oncology, West Cancer Institute, Angers & Nantes., Clement-Duchene C; Department of Pneumology, Lorraine Cancer Institute, Vandoeuvre-les-Nancy., Dansin E; Department of Medical Oncology, Centre Oscar Lambret, Lille., Stancu A; Department of Medical Oncology, Sainte Catherine Institute, Avignon., Pichon E; Department of Pneumology, University Hospital, Tours., Bosquet L; Department of Health Data and Partnerships, Unicancer, Paris., Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, Paris & St Cloud, France., Du Rusquec P; Institut Curie, Institut du Thorax Curie-Montsouris, Paris & St Cloud, France. Electronic address: pauline.durusquec@curie.fr.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103473. Date of Electronic Publication: 2024 Jun 03.
Autor:
Thomas QD; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France.; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute (IRCM) INSERM U1194, University of Montpellier (UM), 34090 Montpellier, France., Chaabouni M; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Al Herk A; Biometrics Unit ICM, Montpellier Cancer Institute, University of Montpellier (UM), 34090 Montpellier, France., Lefevbre C; Pharmacy Department, Montpellier Cancer Institute (ICM), 34090 Montpellier, France., Cavaillon S; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Sinoquet L; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Pouderoux S; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Viala M; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Roca L; Biometrics Unit ICM, Montpellier Cancer Institute, University of Montpellier (UM), 34090 Montpellier, France., Quantin X; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France.; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute (IRCM) INSERM U1194, University of Montpellier (UM), 34090 Montpellier, France.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Feb 29; Vol. 16 (5). Date of Electronic Publication: 2024 Feb 29.
Autor:
Sauvageot S; 1Department of Neurosurgery, Gui de Chauliac University Hospital, Montpellier, France., Mollevi C; 2Desbrest Institute of Epidemiology and Public Health, INSERM, Montpellier, France., Thomas QD; 3Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France.; 4Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute (IRCM), INSERM U1194, Montpellier, France., Charissoux M; 5Department of Radiation Oncology, Montpellier Cancer Institute (ICM), Montpellier, France., Darlix A; 3Department of Medical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France.; 6Institute of Functional Genomics, Montpellier University CNRS, INSERM U1191, Montpellier, France., Rigau V; 6Institute of Functional Genomics, Montpellier University CNRS, INSERM U1191, Montpellier, France.; 7Department of Pathology and Onco-biology, Gui de Chauliac University Hospital, Montpellier, France., Bauchet L; 1Department of Neurosurgery, Gui de Chauliac University Hospital, Montpellier, France.; 6Institute of Functional Genomics, Montpellier University CNRS, INSERM U1191, Montpellier, France., Quantin X; 8Department of Thoracic Oncology, Montpellier Cancer Institute (ICM), Montpellier, France., Pujol JL; 9Thoracic Oncology Unit, University Hospital of Montpellier, Montpellier, France; and.; 10Cancerology Research Institute of Montpellier (IRCM), National Institute for Health and Medical Research (INSERM) Unit-U1194, Montpellier, France., Roch B; 9Thoracic Oncology Unit, University Hospital of Montpellier, Montpellier, France; and.; 10Cancerology Research Institute of Montpellier (IRCM), National Institute for Health and Medical Research (INSERM) Unit-U1194, Montpellier, France., Boetto J; 1Department of Neurosurgery, Gui de Chauliac University Hospital, Montpellier, France.; 6Institute of Functional Genomics, Montpellier University CNRS, INSERM U1191, Montpellier, France.
Publikováno v:
Journal of neurosurgery [J Neurosurg] 2024 Jan 19; Vol. 141 (1), pp. 89-99. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Autor:
Eslami-S Z; Laboratory of Rare Circulating Human Cells - University Medical Center of Montpellier, Montpellier, France.; CREEC/CANECEV, MIVEGEC (CREES), Université de Montpellier, CNRS, IRD, Montpellier, France.; European Liquid Biopsy Society (ELBS), Hamburg, Germany., Cortés-Hernández LE; Laboratory of Rare Circulating Human Cells - University Medical Center of Montpellier, Montpellier, France.; CREEC/CANECEV, MIVEGEC (CREES), Université de Montpellier, CNRS, IRD, Montpellier, France.; European Liquid Biopsy Society (ELBS), Hamburg, Germany., Sinoquet L; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France., Gauthier L; Biometrics Unit, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France., Vautrot V; INSERM 1231, Label 'Ligue National contre le Cancer 'and Label d'Excellence LipSTIC, Dijon, France.; Department of Medical Oncology, Center Georges-François Leclerc, Dijon, France., Cayrefourcq L; Laboratory of Rare Circulating Human Cells - University Medical Center of Montpellier, Montpellier, France.; CREEC/CANECEV, MIVEGEC (CREES), Université de Montpellier, CNRS, IRD, Montpellier, France.; European Liquid Biopsy Society (ELBS), Hamburg, Germany., Avoscan L; Agroécologie, Institut Agro Dijon, CNRS, INRAE, University Bourgogne Franche-Comté, Plateforme DImaCell, F-21000, Dijon, France., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France., Pouderoux S; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France., Viala M; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France., Thomas QD; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France., Lamy PJ; Biopathologie et Génétique des Cancers, Institute d'Analyse Médicale Imagenome, Inovie, Montpellier, France.; Unité de recherche clinique, clinique Beau soleil, Montpellier, France., Quantin X; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier University, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Montpellier University, Montpellier, France., Gobbo J; INSERM 1231, Label 'Ligue National contre le Cancer 'and Label d'Excellence LipSTIC, Dijon, France.; Department of Medical Oncology, Center Georges-François Leclerc, Dijon, France.; Faculty of Medicine, University of Burgundy-Franche-Comté, Dijon, France.; Inserm, CIC1432, Module plurithématique, U2P, Dijon, France., Alix-Panabières C; Laboratory of Rare Circulating Human Cells - University Medical Center of Montpellier, Montpellier, France. c-panabieres@chu-montpellier.fr.; CREEC/CANECEV, MIVEGEC (CREES), Université de Montpellier, CNRS, IRD, Montpellier, France. c-panabieres@chu-montpellier.fr.; European Liquid Biopsy Society (ELBS), Hamburg, Germany. c-panabieres@chu-montpellier.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Jan; Vol. 130 (1), pp. 63-72. Date of Electronic Publication: 2023 Nov 16.
Autor:
Quesada S; Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France., Thomas QD; Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France., Colombo PE; Institut Régional du Cancer de Montpellier (ICM), 34298 Montpellier, France., Fiteni F; Medical Oncology Department, University Hospital of Nîmes, 30900 Nîmes, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jul 10; Vol. 15 (14). Date of Electronic Publication: 2023 Jul 10.
Autor:
Dussart C; CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France., Decaux-Tramoni B; CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France., Quesada S; Institut régional du cancer de Montpellier, département d'oncologie médicale, 34298 Montpellier cedex 5, France., Thomas QD; Institut régional du cancer de Montpellier, département d'oncologie médicale, 34298 Montpellier cedex 5, France., Benzerouale O; CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France., Nicolas E; CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France; Université de Montpellier, Institut Desbrest d'épidémiologie et de santé publique, Inserm UMR 1302, 34090 Montpellier, France., Fiteni F; CHU de Nîmes, service d'oncologie médicale, 4, rue du Professeur-Robert-Debré, 30900 Nîmes, France; Université de Montpellier, Institut Desbrest d'épidémiologie et de santé publique, Inserm UMR 1302, 34090 Montpellier, France. Electronic address: Frederic.fiteni@chu-nimes.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2023 Jul-Aug; Vol. 110 (7-8), pp. 790-801. Date of Electronic Publication: 2023 Apr 11.
Autor:
Colard-Thomas J; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France., Thomas QD; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France.; Oncogenic Pathways in Lung Cancer, Montpellier Cancer Research Institute (IRCM) INSERM U1194, University of Montpellier (UM), 34090 Montpellier, France., Viala M; Department of Medical Oncology, Montpellier Cancer Institute (ICM), University of Montpellier (UM), 34090 Montpellier, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Apr 13; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 13.